Evidence map›Paper›PMID 32891162›Full record

ArticleParasites & vectors2020

Bacillus sphaericus exposure reduced vector competence of Anopheles dirus to Plasmodium yoelii by upregulating the Imd signaling pathway.

Shasha Yu, Pan Wang, Jie Qin, Hong Zheng, Jing Wang, Tingting Liu, Xuesen Yang, Ying Wang

Open access · goldAbstract read
In one paragraph

Article in Parasites & vectors, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.5field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Human Defensin 5 InhibitsTropical medicine and infectious disease · 2024
    Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Shasha YuDepartment of Tropical Medicine, College of Military Preventive Medicine, Army Medical University, Chongqing, 400038, China.
Pan WangDepartment of Tropical Medicine, College of Military Preventive Medicine, Army Medical University, Chongqing, 400038, China.
Jie QinDepartment of Tropical Medicine, College of Military Preventive Medicine, Army Medical University, Chongqing, 400038, China.
Hong ZhengDepartment of Thoracic Surgery, Xinqiao Hospital, Army Medical University, Chongqing, 400037, China.
Jing WangDepartment of Tropical Medicine, College of Military Preventive Medicine, Army Medical University, Chongqing, 400038, China.
Tingting LiuDepartment of Tropical Medicine, College of Military Preventive Medicine, Army Medical University, Chongqing, 400038, China.
Xuesen YangDepartment of Tropical Medicine, College of Military Preventive Medicine, Army Medical University, Chongqing, 400038, China.
Ying WangDepartment of Tropical Medicine, College of Military Preventive Medicine, Army Medical University, Chongqing, 400038, China. wangyingtmmu2016@126.com.
Army Medical University · CN

Funding

National Natural Science Foundation of China 81271875National Natural Science Foundation of China 81702035National Natural Science Foundation of China 81971971Natural Science Foundation of Chongqing cstc2018jcyjAX0182
6 · The paper itself

Abstract

backgroundVector control with Bacillus sphaericus (Bs) is an effective way to block the transmission of malaria. However, in practical application of Bs agents, a sublethal dose effect was often caused by insufficient dosing, and it is little known whether the Bs exposure would affect the surviving mosquitoes' vector capacity to malaria.

methodsA sublethal dose of the Bs 2362 strain was administrated to the early fourth-instar larvae of Anopheles dirus to simulate shortage use of Bs in field circumstance. To determine vector competence, mosquitoes were dissected and the oocysts in the midguts were examined on day 9-11 post-infection with Plasmodium yoelii. Meanwhile, a SYBR quantitative PCR assay was conducted to examine the transcriptional level of the key immune molecules of mosquitoes, and RNA interference was utilized to validate the role of key immune effector molecule TEP1.

resultsThe sublethal dose of Bs treatment significantly reduced susceptibility of An. dirus to P. yoelii, with the decrease of P. yoelii infection intensity and rate. Although there existed a melanization response of adult An. dirus following challenge with P. yoelii, it was not involved in the decrease of vector competence as no significant difference of melanization rates and densities between the control and Bs groups was found. Further studies showed that Bs treatment significantly increased TEP1 expression in the fourth-instar larvae (L4), pupae (Pu), 48 h post-infection (hpi) and 72 hpi (P < 0.001). Further, gene-silencing of TEP1 resulted in disappearance of the Bs impact on vector competence of An. dirus to P. yoelii. Moreover, the transcriptional level of PGRP-LC and Rel2 were significantly elevated by Bs treatment with decreased expression of the negative regulator Caspar at 48 hpi, which implied that the Imd signaling pathway was upregulated by Bs exposure.

conclusionsBs exposure can reduce the vector competence of An. dirus to malaria parasites through upregulating Imd signaling pathway and enhancing the expression of TEP1. The data could not only help us to understand the impact and mechanism of Bs exposure on Anopheles' vector competence to malaria but also provide us with novel clues for wiping out malaria using vector control.

Indexed as

AnophelesPlasmodium yoeliiAnimalsBacillaceaeDisease VectorsDrosophila ProteinsImmunityInsect ControlInsect ProteinsIntestinesLarvaMalariaMosquito VectorsOocystsPest Control, BiologicalDrosophila Proteinsimd protein, DrosophilaInsect ProteinsTEP1 protein, Anopheles gambiaeAnopheles dirusBacillus sphaericusImd signaling pathwayMalariaPlasmodium yoeliiTEP1Vector competence

Identifiers

PMID32891162
PMCPMC7487769
OpenAlexW3083598399

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.